Английская Википедия:Alisertib

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Chembox

Alisertib (MLN8237) is an orally available selective aurora A kinase inhibitor developed by Takeda.[1] It was investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.[2][3] Development was abandoned in 2015 due to poor clinical trial results.[4]

References

Шаблон:Reflist

Шаблон:Organic-compound-stub